Catalyst Wire Dossier Catalyst Wire Dossier

IVACFLU-S

Seasonal trivalent inactivated influenza vaccine (split virion) · Institute of Vaccines and Medical Biologicals, Vietnam
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for IVACFLU-S, covering 2019-01-28 to 2023-07-03. Get the full timeline:

Most recent: Clinical Trial Update: This Study Was Conducted to Evaluate the Safety and Immunogenicity of IVACFLU-S Produced in Children From 6 Months to Under 18 Years Old and the Elderly Over 60 Years Old in Vietnam [Phase 3]

See pricing